CRS is a regional full-service CRO supporting Early-Phase clinical trials in healthy volunteers across Europe.
In-patient Beds for Healthy Volunteers
GCP-Aligned Processes
Years of Experience
Participants Database
Comprehensive CRO services enabling efficient and compliant clinical trials with dedicated regional support.
![<subject>[background image] image of robotics lab (for a robotics and automation)</subject>](images/ChatGPT-Image-14.-mar.-2026-20_44_49.avif)
Parallel regulatory and ethics submissions accelerate study start-up across EU frameworks by coordinating CTA preparation, ethics committee approvals, and regulatory interactions simultaneously while maintaining strict compliance with EMA and national authority requirements.
CTA, ethics submissions and coordinated study activation.
Identification and evaluation of qualified study sites.
Selection and qualification of appropriate clinical study sites.
Safety monitoring and regulatory safety reporting.
Regulatory submissions and lifecycle compliance support.
Central coordination of study execution and timelines.
Risk-based monitoring for safety and data integrity.
Audits, compliance oversight, and inspection readiness.
Integrated Data Management and Statistical services.
Our CRS Team has accumulated extensive expertise across a broad spectrum of therapeutic areas, conducting studies in all phases and delivering results for sponsors worldwide.
Respiratory diseases
Parkinson's disease, MSA, PSP
Neurodegenerative research
Metal chelation therapy
Sickle Cell Disease, Thalassemia
Endocrinology & metabolic
Breast cancer, Prostate cancer
GERD & GI disorders
Including HIV
Phenylketonuria & rare pediatric conditions
TED, Graves disease
Epilepsy studies
Supporting efficient and compliant early-phase clinical trials with experienced clinical teams.
We provide focused early-phase clinical services for studies conducted in healthy volunteers, aligned with European regulatory requirements. Our experienced clinical teams support pilot and pharmacokinetic studies with comprehensive safety monitoring, efficient study conduct, and high-quality data generation for early development decisions.
![<subject>[background image] image of robotics lab (for a robotics and automation)</subject>](images/6945400a1cd9b04424846d4e_1a532569-60dc-46de-a907-54dc7efb980a.avif)
Safety-driven first-in-human trials with intensive medical monitoring and real-time data review for early decision making.
Early-phase clinical studies in healthy volunteers, including single and multiple ascending dose designs.
EMA-guided studies for generics, reformulations, and fixed-dose combinations.
Bioavailability and bioequivalence trials for generics, reformulations, and fixed-dose combinations in line with EMA guidance.
Pharmacokinetic and pilot studies supporting early decision-making and development planning.
Hybrid early-phase designs to accelerate proof-of-concept and support regulatory and development decisions.
Validated data capture, cleaning, and biostatistical analysis for compliance
“CRS is a regionally operating, mid-sized, full-service CRO aiming to improve access to new therapies for the patients in need.”
Organizations rely on our standards regulated solutions for compliance and product data accuracy.
“20+ years of experience in Phase I-IV clinical development”
“Enabling the future Development of Clinical Research.”
“Data resolution consistentcy and compliance requirements.”
“Standards-aligned infrastructure for Clinical Research data.”
Submit your request or general information.